Dr. Sruthi Devarinti, DO

Dr. Devarinti practices at St Lukes University Hospital Bethlehem in Bethlehem, Pennsylvania.

Dr. Devarinti's NPI, 1417396276, was assigned on June 14, 2013. Dr. Devarinti holds Pennsylvania license OS018820.

Dr. Devarinti's primary practice is St Lukes University Hospital Bethlehem, at 801 Ostrum St, Bethlehem, PA 18015 in Northampton County. The practice phone is (610) 954-4000.

Dr. Devarinti's primary practice is St Lukes University Hospital Bethlehem in Bethlehem, Pennsylvania. Dr. Devarinti is also affiliated with St. Luke's University Hospital - Bethlehem Campus. The medical group on file is St. Luke's South Mountain Family Practice. Dmand AI also links Dr. Devarinti to 4 more hospitals, 2 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Devarinti practices, 6 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Devarinti's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Devarinti is licensed in Pennsylvania.

CMS data shows 462 Medicare services from Dr. Devarinti across 9 procedure codes in 2024, for 301 Medicare patients. Medicare paid $47,737 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 301 Medicare patients who saw Dr. Devarinti in 2024. The largest group is 65 to 74, with 106 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 17% are also on Medicaid. Their average risk score is 2.15, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Devarinti's median patient age at 71, with 54% women.

In 2023, Dr. Devarinti wrote 15 Medicare Part D claims. They cover 1 drug, with $19,838 in total drug cost. In 2022, CMS named 410 claims across 20 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Dr. Devarinti for performance year 2024, reported through an alternative payment model (APM). Dr. Devarinti accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Devarinti as offering telehealth.

CMS Open Payments shows 83 general payments to Dr. Devarinti from 12 drug and device companies from 2016 to 2022. Food and beverage make up the largest share, 92% of the total. Teva Pharmaceuticals USA, Inc. paid the most, $892.